The largest database of trusted experimental protocols

Marinol

Manufactured by Solvay

Marinol is a laboratory equipment product designed for analytical and research applications. It serves as a tool for performing various chemical and biochemical analyses. The core function of Marinol is to facilitate precise measurements and data collection in a controlled laboratory environment.

Automatically generated - may contain errors

Lab products found in correlation

6 protocols using marinol

1

Oral Δ9-THC Dose-Response Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Δ9-THC (Marinol® [dronabinol]; Solvay Pharmaceuticals; 7.5 mg and 15 mg) was placed in opaque capsules with dextrose filler. Placebo capsules contained only dextrose. These two doses enable assessment of dose–response effects. The 15 mg and 7.5 mg doses reflect the amount of Δ9-THC in one-half and one-quarter of a cannabis cigarette containing 0.2 g of 15% Δ9-THC, respectively. These oral doses of Δ9-THC produce both subjective and behavioral effects (Broyd et al. 2016 (link); Hartman and Huestis 2013 (link); Pabon and de Wit 2019 (link)).
+ Open protocol
+ Expand
2

Cannabinoid Dose-Response Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
THC (Marinol®; Solvay Pharmaceuticals) was placed in opaque, size 00 capsules with dextrose filler. Placebo capsules contained only dextrose (0 mg THC). Chosen doses produce reliable subjective and cardiovascular effects without adverse effects [45 (link), 46 (link)]. Experiment 1: Participants received a placebo capsule and a 15 mg capsule in two randomized, counterbalanced sessions. Experiment 2: Participants received a placebo capsule, a 7.5 mg capsule, and a 15 mg capsule in three randomized, counterbalanced sessions.
+ Open protocol
+ Expand
3

Dronabinol Capsule Formulation Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
THC capsules (2.5, 5 or 10 mg dronabinol, Marinol®; Solvay Pharmaceuticals, Marietta, Georgia) were placed inside opaque size 00 capsules with dextrose filler. Placebo capsules contained only dextrose filler.
+ Open protocol
+ Expand
4

Marinol® Capsules for Memory Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fifteen mg of THC (Marinol®; Solvay Pharmaceuticals) was placed in opaque size 00 capsules with dextrose filler. Placebo capsules contained dextrose only. This dose of THC is within the range shown to affect memory encoding in prior work [3 (link),4 (link)].
+ Open protocol
+ Expand
5

Oral Δ9-THC and Gabapentin Co-Administration

Check if the same lab product or an alternative is used in the 5 most similar protocols
Subjects consumed a low-fat snack approximately 20 minutes prior to drug administration. Doses of Δ9-THC were prepared by encapsulating commercially available capsules of Marinol® (Δ9-THC in sesame oil, Solvay Pharmaceuticals Inc., Marietta, GA) and a generic formulation of gabapentin (Ascend Laboratories, Montvale, NJ) in opaque green size 00 capsules. For reference, the acute recommended Δ9-THC dosing range in adults for appetite stimulation and the prevention of nausea and vomiting is 2.5 to 20 mg (Marinol® product information, 2006 ). The recommended starting therapeutic oral dose of gabapentin is 300–400 mg, administered three times a day, and titrated up to a clinically effective maintenance dose of 1800–3600 mg/day (Gabapentin product information, 2011 ). However, single-dose clinical research studies have administered 1200 mg, the maximum gabapentin dose administered in this study, on an acute basis without dose titration (e.g., Gordi et al., 2008 (link)). Gabapentin and Δ9-THC were administered concurrently, consistent with the onset of their peak concentrations following oral dosing (Gidal et al., 1998 (link); Lile et al., 2013 (link)). The use of oral Δ9-THC and gabapentin in this study was for investigational purposes.
+ Open protocol
+ Expand
6

Evaluating Cannabinoid and Benzodiazepine Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Across their participation, subjects received placebo, 5, 15 and 30 mg of Δ9-THC, and 5 and 10 mg of diazepam, alone and in combination. Doses of Δ9-THC were prepared by encapsulating commercially available capsules of Marinol® (Δ9-THC in sesame oil, Solvay Pharmaceuticals, Marietta, GA) in three opaque green size 00 capsules. A generic formulation of diazepam was administered in one opaque blue/white size 0 capsule. Cornstarch was used to fill the remainder of all capsules. Placebo capsules contained only cornstarch. For reference, the acute recommended Δ9-THC dosing range in adults for appetite stimulation and the prevention of nausea and vomiting is 2.5 to 20 mg (Marinol® Product Information, 2006 ). The recommended acute oral dosage of diazepam for the treatment of anxiety is 2-10 mg (Valium® Product Information, 2013 ).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!